pablo ricardo arantes
University of California, Riverside
Riverside, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
- Frontiers in Drug Discovery
- In silico Methods and Artificial Intelligence for Drug Discovery
- Editorial Board
Type at least 3 characters
171 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
jules clement nguedia assob
Department of Pharmaceutical Sciences, Faculty of Medicine and Pharmaceutical science, University of Douala
Douala, Cameroon
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
amit kumar banerjee
Indian Institute of Chemical Technology (CSIR)
Hyderabad, India
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
smith b. babiaka, phd
Department of Microbial Bioactive Compounds, Institute for Microbiology and Infection Medicine, University of Tuebingen
Tuebingen, Germany
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
rohit bavi
China Pharmaceutical University
Nanjing, China
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
philippe belle ebanda kedi
Faculty of Science, University of Douala
Douala, Cameroon
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
francois berenger
The University of Tokyo
Bunkyo, Japan
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
marcel bermudez
University of Münster
Münster, Germany
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
vincent blay
University of California, Santa Cruz
Santa Cruz, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
emre fatih bülbül
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
Saarbrücken, Germany
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
ernesto raul caffarena
Oswaldo Cruz Foundation (Fiocruz)
Rio de Janeiro, Brazil
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
zixuan cang
North Carolina State University
Raleigh, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
luca carlino
AstraZeneca (United Kingdom)
London, United Kingdom
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
payal chatterjee
Cogent Biosciences
Boulder, CO, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
jaeyoon chung
Chobanian & Avedisian School of Medicine, Boston University
Boston, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
francisco cortés-benítez
Autonomous Metropolitan University Xochimilco Campus
Coyoacán, Mexico
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery